Michael Bigham, Chairman and CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 10,150 shares at $23.58 ($239K) on 2017-07-05, disclosed to the SEC on 2017-07-06.
Open-market sale of $239k PRTK by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.58 | 5,075 | $120K | 50.0% |
| 2 | $23.58 | 5,075 | $120K | 50.0% |
| Total | $23.58 avg | 10,150 | $239K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $164K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |